Skip to main content
Top
Published in: Cancer Causes & Control 3/2013

01-03-2013 | Original paper

Subtype of dietary fat in relation to risk of Hodgkin lymphoma: a population-based case–control study in Connecticut and Massachusetts

Authors: Yongshun Gao, Qian Li, Bryan A. Bassig, Ellen T. Chang, Min Dai, Qin Qin, Yawei Zhang, Tongzhang Zheng

Published in: Cancer Causes & Control | Issue 3/2013

Login to get access

Abstract

Few epidemiological studies have examined the relationship between dietary fat, which may affect immune function and risk of Hodgkin lymphoma (HL). The aim of this study was to test the hypothesis that high dietary intake of fat and specific subtypes of fat is associated with the risk of HL among 486 HL cases and 630 population-based controls recruited between 1997 and 2000 in Connecticut and Massachusetts. Unconditional logistic regression was used to calculate odds ratios (ORs) and 95 % confidence intervals (CIs) stratified by age and gender. Among younger adults, HL risk was significantly and positively associated with higher intake of saturated fat [ORs for increasing quartiles = 1.3, 1.8, and 2.1; p trend = 0.04] and negatively associated with higher intake of monounsaturated fat [ORs for increasing quartiles = 0.5, 0.5, and 0.4; p trend = 0.03), after adjustment for potential confounders including lifestyle and other dietary factors. The associations with saturated fat (ORs for increasing quartile = 2.4, 3.2, and 4.4; p trend < 0.01] and monounsaturated fat (ORs for increasing quartile = 0.3, 0.6, and 0.3; p trend = 0.04) were most apparent in younger women, whereas there was no significant association between intake of total fat or any type of fat and risk of HL in older females or younger or older males. These findings show that the associations between dietary fat and risk of HL may vary by gender and age and require confirmation in other populations.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kelley DS, Bendich A (1996) Essential nutrients and immunologic functions. Am J Clin Nutr 63:994S–996SPubMed Kelley DS, Bendich A (1996) Essential nutrients and immunologic functions. Am J Clin Nutr 63:994S–996SPubMed
2.
go back to reference Cameron RG, Armstrong D, Clandinin MT, Cinader B (1986) Changes in lymphoma development in female SJL/J mice as a function of the ratio in low polyunsaturated/high polyunsaturated fat diet. Cancer Lett 30:175–180PubMedCrossRef Cameron RG, Armstrong D, Clandinin MT, Cinader B (1986) Changes in lymphoma development in female SJL/J mice as a function of the ratio in low polyunsaturated/high polyunsaturated fat diet. Cancer Lett 30:175–180PubMedCrossRef
3.
go back to reference Jose DG, Good RA (1973) Quantitative effects of nutritional essential amino acid deficiency upon immune responses to tumors in mice. J Exp Med 137:1–9PubMedCrossRef Jose DG, Good RA (1973) Quantitative effects of nutritional essential amino acid deficiency upon immune responses to tumors in mice. J Exp Med 137:1–9PubMedCrossRef
4.
go back to reference Wallace FA, Miles EA, Evans C, Stock TE, Yaqoob P, Calder PC (2001) Dietary fatty acids influence the production of Th1—but not Th2-type cytokines. J Leukoc Biol 69:449–457PubMed Wallace FA, Miles EA, Evans C, Stock TE, Yaqoob P, Calder PC (2001) Dietary fatty acids influence the production of Th1—but not Th2-type cytokines. J Leukoc Biol 69:449–457PubMed
5.
go back to reference Skibola CF (2007) Obesity, diet and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 16:392–395PubMedCrossRef Skibola CF (2007) Obesity, diet and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 16:392–395PubMedCrossRef
6.
go back to reference Kelley DS, Dougherty RM, Branch LB, Taylor PC, Iacono JM (1992) Concentration of dietary N-6 polyunsaturated fatty acids and the human immune status. Clin Immunol Immunopathol 62:240–244PubMedCrossRef Kelley DS, Dougherty RM, Branch LB, Taylor PC, Iacono JM (1992) Concentration of dietary N-6 polyunsaturated fatty acids and the human immune status. Clin Immunol Immunopathol 62:240–244PubMedCrossRef
7.
go back to reference Polesel J, Talamini R, Montella M et al (2006) Linoleic acid, vitamin D and other nutrient intakes in the risk of non-Hodgkin lymphoma: an Italian case–control study. Ann Oncol 17:713–718PubMedCrossRef Polesel J, Talamini R, Montella M et al (2006) Linoleic acid, vitamin D and other nutrient intakes in the risk of non-Hodgkin lymphoma: an Italian case–control study. Ann Oncol 17:713–718PubMedCrossRef
8.
go back to reference Zheng T, Holford TR, Leaderer B et al (2004) Diet and nutrient intakes and risk of non-Hodgkin’s lymphoma in Connecticut women. Am J Epidemiol 159:454–466PubMedCrossRef Zheng T, Holford TR, Leaderer B et al (2004) Diet and nutrient intakes and risk of non-Hodgkin’s lymphoma in Connecticut women. Am J Epidemiol 159:454–466PubMedCrossRef
9.
go back to reference Purdue MP, Bassani DG, Klar NS, Sloan M, Kreiger N (2004) Dietary factors and risk of non-Hodgkin lymphoma by histologic subtype: a case–control analysis. Cancer Epidemiol Biomarkers Prev 13:1665–1676PubMed Purdue MP, Bassani DG, Klar NS, Sloan M, Kreiger N (2004) Dietary factors and risk of non-Hodgkin lymphoma by histologic subtype: a case–control analysis. Cancer Epidemiol Biomarkers Prev 13:1665–1676PubMed
10.
go back to reference Zhang S, Hunter DJ, Rosner BA et al (1999) Dietary fat and protein in relation to risk of non-Hodgkin’s lymphoma among women. J Natl Cancer Inst 91:1751–1758PubMedCrossRef Zhang S, Hunter DJ, Rosner BA et al (1999) Dietary fat and protein in relation to risk of non-Hodgkin’s lymphoma among women. J Natl Cancer Inst 91:1751–1758PubMedCrossRef
11.
go back to reference Chiu BC, Cerhan JR, Folsom AR et al (1996) Diet and risk of non-Hodgkin lymphoma in older women. JAMA 275:1315–1321PubMedCrossRef Chiu BC, Cerhan JR, Folsom AR et al (1996) Diet and risk of non-Hodgkin lymphoma in older women. JAMA 275:1315–1321PubMedCrossRef
12.
go back to reference Cross AJ, Ward MH, Schenk M et al (2006) Meat and meat-mutagen intake and risk of non-Hodgkin lymphoma: results from a NCI-SEER case–control study. Carcinogenesis 27:293–297PubMedCrossRef Cross AJ, Ward MH, Schenk M et al (2006) Meat and meat-mutagen intake and risk of non-Hodgkin lymphoma: results from a NCI-SEER case–control study. Carcinogenesis 27:293–297PubMedCrossRef
13.
go back to reference Franceschi S, Serraino D, Carbone A, Talamini R, La Vecchia C (1989) Dietary factors and non-Hodgkin’s lymphoma: a case–control study in the northeastern part of Italy. Nutr Cancer 12:333–341PubMedCrossRef Franceschi S, Serraino D, Carbone A, Talamini R, La Vecchia C (1989) Dietary factors and non-Hodgkin’s lymphoma: a case–control study in the northeastern part of Italy. Nutr Cancer 12:333–341PubMedCrossRef
14.
go back to reference Tavani A, Pregnolato A, Negri E et al (1997) Diet and risk of lymphoid neoplasms and soft tissue sarcomas. Nutr Cancer 27:256–260PubMedCrossRef Tavani A, Pregnolato A, Negri E et al (1997) Diet and risk of lymphoid neoplasms and soft tissue sarcomas. Nutr Cancer 27:256–260PubMedCrossRef
15.
go back to reference Chang ET, Zheng T, Lennette ET et al (2004) Heterogeneity of risk factors and antibody profiles in Epstein–Barr virus genome-positive and -negative Hodgkin lymphoma. J Infect Dis 189:2271–2281PubMedCrossRef Chang ET, Zheng T, Lennette ET et al (2004) Heterogeneity of risk factors and antibody profiles in Epstein–Barr virus genome-positive and -negative Hodgkin lymphoma. J Infect Dis 189:2271–2281PubMedCrossRef
16.
go back to reference Bohlke K, Harlow BL, Cramer DW, Spiegelman D, Mueller NE (1999) Evaluation of a population roster as a source of population controls: the Massachusetts Resident Lists. Am J Epidemiol 150:354–358PubMedCrossRef Bohlke K, Harlow BL, Cramer DW, Spiegelman D, Mueller NE (1999) Evaluation of a population roster as a source of population controls: the Massachusetts Resident Lists. Am J Epidemiol 150:354–358PubMedCrossRef
17.
go back to reference US Census Bureau (2002) 2000 Census of population and housing, summary file 3[Connecticut]. US Census Bureau, Washington, DC US Census Bureau (2002) 2000 Census of population and housing, summary file 3[Connecticut]. US Census Bureau, Washington, DC
18.
go back to reference Chang ET, Zheng T, Weir EG et al (2004) Childhood social environment and Hodgkin’s lymphoma: new findings from a population-based case–control study. Cancer Epidemiol Biomarkers Prev 13:1361–1370PubMed Chang ET, Zheng T, Weir EG et al (2004) Childhood social environment and Hodgkin’s lymphoma: new findings from a population-based case–control study. Cancer Epidemiol Biomarkers Prev 13:1361–1370PubMed
19.
go back to reference Chang ET, Zheng T, Weir EG et al (2004) Aspirin and the risk of Hodgkin’s lymphoma in a population-based case–control study. J Natl Cancer Inst 96:305–315PubMedCrossRef Chang ET, Zheng T, Weir EG et al (2004) Aspirin and the risk of Hodgkin’s lymphoma in a population-based case–control study. J Natl Cancer Inst 96:305–315PubMedCrossRef
20.
go back to reference Morton LM, Turner JJ, Cerhan JR et al (2007) Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood 110:695–708PubMedCrossRef Morton LM, Turner JJ, Cerhan JR et al (2007) Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood 110:695–708PubMedCrossRef
21.
go back to reference Ambinder RF, Mann RB (1994) Epstein–Barr-encoded RNA in situ hybridization: diagnostic applications. Hum Pathol 25:602–605PubMedCrossRef Ambinder RF, Mann RB (1994) Epstein–Barr-encoded RNA in situ hybridization: diagnostic applications. Hum Pathol 25:602–605PubMedCrossRef
22.
go back to reference Gulley ML, Glaser SL, Craig FE et al (2002) Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein–Barr virus in Hodgkin lymphoma. Am J Clin Pathol 117:259–267PubMedCrossRef Gulley ML, Glaser SL, Craig FE et al (2002) Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein–Barr virus in Hodgkin lymphoma. Am J Clin Pathol 117:259–267PubMedCrossRef
23.
go back to reference Willett WC, Sampson L, Stampfer MJ et al (1985) Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 122:51–65PubMed Willett WC, Sampson L, Stampfer MJ et al (1985) Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 122:51–65PubMed
24.
go back to reference Willett WC, Howe GR, Kushi LH (1997) Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 65:1220S–1228S discussion 9S–31SPubMed Willett WC, Howe GR, Kushi LH (1997) Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 65:1220S–1228S discussion 9S–31SPubMed
25.
go back to reference Greenland S (1989) Modeling and variable selection in epidemiologic analysis. Am J Public Health 79:340–349PubMedCrossRef Greenland S (1989) Modeling and variable selection in epidemiologic analysis. Am J Public Health 79:340–349PubMedCrossRef
26.
go back to reference Glaser SL (1986) Recent incidence and secular trends in Hodgkin’s disease and its histologic subtypes. J Chronic Dis 39:789–798PubMedCrossRef Glaser SL (1986) Recent incidence and secular trends in Hodgkin’s disease and its histologic subtypes. J Chronic Dis 39:789–798PubMedCrossRef
27.
go back to reference Glaser SL, Swartz WG (1990) Time trends in Hodgkin’s disease incidence. The role of diagnostic accuracy. Cancer 66:2196–2204PubMedCrossRef Glaser SL, Swartz WG (1990) Time trends in Hodgkin’s disease incidence. The role of diagnostic accuracy. Cancer 66:2196–2204PubMedCrossRef
29.
go back to reference Howlader NNA, Krapcho M, Neyman N, Aminou R, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA (2012) SEER cancer statistics review, 1975–2009 (Vintage 2009 Populations). National Cancer Institute, Bethesda Howlader NNA, Krapcho M, Neyman N, Aminou R, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA (2012) SEER cancer statistics review, 1975–2009 (Vintage 2009 Populations). National Cancer Institute, Bethesda
30.
go back to reference Chen YT, Zheng T, Chou MC, Boyle P, Holford TR (1997) The increase of Hodgkin’s disease incidence among young adults. Experience in Connecticut, 1935–1992. Cancer 79:2209–2218PubMedCrossRef Chen YT, Zheng T, Chou MC, Boyle P, Holford TR (1997) The increase of Hodgkin’s disease incidence among young adults. Experience in Connecticut, 1935–1992. Cancer 79:2209–2218PubMedCrossRef
31.
go back to reference Glaser SL, Clarke CA, Stearns CB, Dorfman RF (2001) Age variation in Hodgkin’s disease risk factors in older women: evidence from a population-based case–control study. Leuk Lymphoma 42:997–1004PubMedCrossRef Glaser SL, Clarke CA, Stearns CB, Dorfman RF (2001) Age variation in Hodgkin’s disease risk factors in older women: evidence from a population-based case–control study. Leuk Lymphoma 42:997–1004PubMedCrossRef
32.
go back to reference Glaser SL, Clarke CA, Nugent RA, Stearns CB, Dorfman RF (2002) Social class and risk of Hodgkin’s disease in young–adult women in 1988–94. Int J Cancer 98:110–117PubMedCrossRef Glaser SL, Clarke CA, Nugent RA, Stearns CB, Dorfman RF (2002) Social class and risk of Hodgkin’s disease in young–adult women in 1988–94. Int J Cancer 98:110–117PubMedCrossRef
33.
go back to reference Turner JJ, Morton LM, Linet MS et al (2010) InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. Blood 116:e90–e98PubMedCrossRef Turner JJ, Morton LM, Linet MS et al (2010) InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. Blood 116:e90–e98PubMedCrossRef
34.
go back to reference Zurier RB (1993) Fatty acids, inflammation and immune responses. Prostaglandins Leukot Essent Fatty Acids 48:57–62PubMedCrossRef Zurier RB (1993) Fatty acids, inflammation and immune responses. Prostaglandins Leukot Essent Fatty Acids 48:57–62PubMedCrossRef
35.
36.
go back to reference Vitale JJ, Broitman SA (1981) Lipids and immune function. Cancer Res 41:3706–3710PubMed Vitale JJ, Broitman SA (1981) Lipids and immune function. Cancer Res 41:3706–3710PubMed
37.
go back to reference Cinader B, Clandinin MT, Hosokawa T, Robblee NM (1983) Dietary fat alters the fatty acid composition of lymphocyte membranes and the rate at which suppressor capacity is lost. Immunol Lett 6:331–337PubMedCrossRef Cinader B, Clandinin MT, Hosokawa T, Robblee NM (1983) Dietary fat alters the fatty acid composition of lymphocyte membranes and the rate at which suppressor capacity is lost. Immunol Lett 6:331–337PubMedCrossRef
38.
go back to reference Biggar RJ, Jaffe ES, Goedert JJ, Chaturvedi A, Pfeiffer R, Engels EA (2006) Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood 108:3786–3791PubMedCrossRef Biggar RJ, Jaffe ES, Goedert JJ, Chaturvedi A, Pfeiffer R, Engels EA (2006) Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood 108:3786–3791PubMedCrossRef
39.
go back to reference Landgren O, Engels EA, Pfeiffer RM et al (2006) Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case–control study in Scandinavia. J Natl Cancer Inst 98:1321–1330PubMedCrossRef Landgren O, Engels EA, Pfeiffer RM et al (2006) Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case–control study in Scandinavia. J Natl Cancer Inst 98:1321–1330PubMedCrossRef
40.
go back to reference Vajdic CM, McDonald SP, McCredie MR et al (2006) Cancer incidence before and after kidney transplantation. JAMA 296:2823–2831PubMedCrossRef Vajdic CM, McDonald SP, McCredie MR et al (2006) Cancer incidence before and after kidney transplantation. JAMA 296:2823–2831PubMedCrossRef
41.
go back to reference Engels EA, Pfeiffer RM, Fraumeni JF Jr et al (2011) Spectrum of cancer risk among US solid organ transplant recipients. JAMA 306:1891–1901PubMedCrossRef Engels EA, Pfeiffer RM, Fraumeni JF Jr et al (2011) Spectrum of cancer risk among US solid organ transplant recipients. JAMA 306:1891–1901PubMedCrossRef
42.
43.
go back to reference Bianchini F, Kaaks R, Vainio H (2002) Overweight, obesity, and cancer risk. Lancet Oncol 3:565–574PubMedCrossRef Bianchini F, Kaaks R, Vainio H (2002) Overweight, obesity, and cancer risk. Lancet Oncol 3:565–574PubMedCrossRef
44.
go back to reference Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE (2000) The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21:215–244PubMedCrossRef Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE (2000) The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21:215–244PubMedCrossRef
45.
go back to reference Jones JI, Clemmons DR (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3–34PubMed Jones JI, Clemmons DR (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3–34PubMed
Metadata
Title
Subtype of dietary fat in relation to risk of Hodgkin lymphoma: a population-based case–control study in Connecticut and Massachusetts
Authors
Yongshun Gao
Qian Li
Bryan A. Bassig
Ellen T. Chang
Min Dai
Qin Qin
Yawei Zhang
Tongzhang Zheng
Publication date
01-03-2013
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 3/2013
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-012-0136-2

Other articles of this Issue 3/2013

Cancer Causes & Control 3/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine